Search results

Hear from our most recent addition to the nandin Innovation Centre, Tomonori Hu, Founder and CEO of Miriad.

Scientists have found a new approach to killing antibiotic-resistant bacteria using lipid nanoparticles that target specific layers on the surface of the bacterial cell.

ANSTO has a role in the global monitoring system on behalf of Australia to ensure non-proliferation of weapons and that nuclear technology is only used for peaceful purposes.

NSTO’S major project to introduce eight new beamlines at the Australian Synchrotron has reached a milestone with the delivery of ‘first light’ to the new MEX-1 beamline.

The nandin Innovation Centre and Southern Sydney Innovation Network are excited to host Dr Tiffany Vora, Expert and Vice Chair Digital Biology and Medicine at Singularity University, for two presentations on Diversity and Inclusion and Biotech, along with an interview with DR KC Huang.

Investigations of various aspects of magnetism can be conducted on all neutron-scattering instruments at OPAL.

Modelling and experimentation - a powerful combination in probing mechanical properties of ion irradiated materials through nanoindentation.

Neutron Capture Enhanced Particle Therapy developed at ANSTO.

Imaging protocol assesses molecular mechanism of work in the treatment of deadly childhood cancer neuroblastoma.

Applications are now being accepted for the Industry foundations Scholarship.

A specialist in particle therapy treatment planning from the Mayo Clinic in the US, Professor Chris Beltran, recently visited ANSTO for an exchange for information.